Search hospitals
>
Maine
>
Portland
Maine Medical Center
Claim this profile
Portland, Maine 04102
Global Leader in Coronary Artery Disease
Global Leader in Ovarian Cancer
Conducts research for Cystic Fibrosis
Conducts research for Prostate Cancer
Conducts research for Fallopian Tube Cancer
319 reported clinical trials
21 medical researchers
Summary
Maine Medical Center is a medical facility located in Portland, Maine. This center is recognized for care of Coronary Artery Disease, Ovarian Cancer, Cystic Fibrosis, Prostate Cancer, Fallopian Tube Cancer and other specialties. Maine Medical Center is involved with conducting 319 clinical trials across 454 conditions. There are 21 research doctors associated with this hospital, such as Eric C. Larsen, Matthew D. Cheney, Leslie Bradford, MD, and Christine Lu-Emerson.
Area of expertise
Coronary Artery Disease
Maine Medical Center has run 28 trials for Coronary Artery Disease.
Ovarian Cancer
Maine Medical Center has run 21 trials for Ovarian Cancer. Some of their research focus areas include:
Top PIs
Eric C. Larsen
Maine Children's Cancer Program
8 years of reported clinical research
Matthew D. Cheney
Maine Medical Center- Scarborough Campus
5 years of reported clinical research
Leslie Bradford, MD
Maine Medical Center- Scarborough Campus
2 years of reported clinical research
Christine Lu-Emerson
Maine Medical Center- Scarborough Campus
4 years of reported clinical research
Clinical Trials running at Maine Medical Center
Prostate Cancer
Lung Cancer
Ovarian Cancer
Breast Cancer
Esophageal cancer
Cancer
Atrial Fibrillation
Kidney Cancer
Breast cancer
Gastric cancer
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting
2 awards
Phase 3
Shorter vs Usual Radiation Therapy
for Prostate Cancer
This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a patient and deliver radiation to tumors with high precision. This method may kill tumor cells with fewer doses over a shorter period of time. This trial is evaluating if shorter duration radiation prevents cancer from coming back as well as the usual radiation treatment.
Recruiting
2 awards
Phase 3
10 criteria
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting
2 awards
Phase 3
30 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Maine Medical Center?
Maine Medical Center is a medical facility located in Portland, Maine. This center is recognized for care of Coronary Artery Disease, Ovarian Cancer, Cystic Fibrosis, Prostate Cancer, Fallopian Tube Cancer and other specialties. Maine Medical Center is involved with conducting 319 clinical trials across 454 conditions. There are 21 research doctors associated with this hospital, such as Eric C. Larsen, Matthew D. Cheney, Leslie Bradford, MD, and Christine Lu-Emerson.
Where is Maine Medical Center located?
Maine Medical Center is located at 22 Bramhall St, Portland, ME 04102.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Maine Medical Center, please reach out to Patient Financial Services via MyChart or by calling 1-866-804-2499. Our team is available Monday through Friday, from 8 am to 4:30 pm.
What insurance does Maine Medical Center accept?
Maine Medical Center, a key entity within the MaineHealth system, accepts a broad range of major insurance providers, including but not limited to Aetna, Anthem, Cigna, and Medicare. Patients are encouraged to verify their insurance coverage, including copayments, coinsurances, and deductibles, directly with their insurance carrier or network. Note that coverage for specific services, such as behavioral health, may vary by location and could be managed by subsidiary companies under your health plan.
What awards or recognition has Maine Medical Center received?
Maine Medical Center, acclaimed as Maine's top hospital for 11 consecutive years by U.S. News & World Report, excels in Urology and 13 common procedures and conditions. It stands as an International Learning Collaborative Founding Partner, underscoring its commitment to Fundamental Care globally. The MaineHealth Institute for Research pioneers in biomedical research, advancing patient care through extensive research and clinical trials.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.